SOURCE: BIOLASE Technology, Inc.

March 01, 2007 16:05 ET

BIOLASE Fourth Quarter and Fiscal Year 2006 Operating Results Conference Call to Be Held March 14 at 9:00 a.m. EDT

IRVINE, CA -- (MARKET WIRE) -- March 1, 2007 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, announced today that it has rescheduled its conference call originally scheduled for next week. The Company will now host its conference call on Wednesday, March 14 at 9:00 a.m. Eastern Time to discuss its operating results for the fourth quarter and year ended December 31, 2006. The Company also indicated that it expects to timely file its Annual Report on Form 10-K with the Securities and Exchange Commission.

The Company's results release will be distributed at approximately 7:30 a.m. Eastern Time on March 14, 2007. To listen to the conference call live via the internet, visit the Investors section of the BIOLASE website at Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software. A replay will be available on BIOLASE's website.

To listen to the conference call live via telephone, please dial (866) 700-7441 from the U.S. or, for international callers, please dial (617) 213-8839, approximately 10 minutes before the start time. Enter passcode number 43719161. A telephone replay will be available for two days by dialing (888) 286-8010 from the U.S., or (617) 801-6888 for international callers, and entering passcode number 82189305.

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (, the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

Contact Information

  • For further information, please contact:

    Jeffrey W. Jones
    President & CEO
    Richard L. Harrison
    Executive Vice President and CFO
    BIOLASE Technology, Inc.

    Jill Bertotti
    Allen & Caron